AI biotech Enveda raises $311M to advance nature-derived drugs into clinical trials
The funding round values the company at $2 billion as it pushes forward treatments for skin conditions and weight-loss maintenance after stopping GLP-1 drugs.
Enveda, an AI-driven biotech company, has secured $311 million in new funding to advance its pipeline of nature-derived drugs into clinical trials, according to TechCrunch.
The funding round values the company at $2 billion, reflecting continued investor interest in AI-assisted approaches to drug discovery that draw on naturally occurring compounds rather than purely synthetic chemistry.
Among the treatments currently in testing are therapies for skin conditions, as well as drugs aimed at helping patients preserve weight loss after discontinuing GLP-1 medications, a class of drugs that has reshaped the weight-management treatment landscape in recent years.
The new capital is expected to support Enveda's efforts to move these candidate treatments further along the clinical trial process, a critical and often costly stage in bringing new drugs to market.
The raise adds to a broader wave of investment in AI-focused biotech companies, as the sector continues to attract significant funding on the premise that machine learning can accelerate the identification and development of viable drug candidates.
Sources
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles
Two Indian Nationals Charged With Smuggling Counterfeit Ozempic From China, DOJ Says
The Justice Department announced criminal charges against two Indian nationals accused of smuggling counterfeit versions of the weight-loss drug Ozempic from China into Florida.
OpenAI Reportedly in Talks to Raise $30 Billion at $1.4 Trillion Valuation
OpenAI is said to be negotiating a new funding round that would value the company at $1.4 trillion, reportedly its last before a delayed 2027 public listing.
OpenAI DevDay 2026: AI Lab Unveils Dots Agents, in Talks for New Funding Round
The developer conference featured Sam Altman's keynote alongside a wave of new product announcements.
Soho House Venue Under Investigation Over Food Safety Complaint
Hackney Council is investigating a Soho House members' club venue after a former chef raised food safety concerns with local authorities.
Pakistan and Gavi hold talks on vaccine allocation and procurement
Officials discussed the country's vaccine needs, future allocation under Gavi's next planning period, and procurement of the Hexa vaccine.
Pakistan reviews HIV and Hepatitis C prevention measures at technical meeting
The fourth Technical Working Group session examined infection control and safe healthcare practices at the national health ministry.